OCIAD2 promotes epithelial to mesenchymal transition during mesendoderm specification of human pluripotent stem cells
RNA-seq (gene expression) · human · 21 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 21 samples: 6 conditions, mostly with about 4 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE307502_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1321888 and SRA study SRP618432. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 21 samples.
How we read this: 6 replicated groups read from 21 sample titles; they account for 21 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9225664 BJNHem20 cells, WT, day 0, replicate 1 BJNHem20 cells, WT, day…
- GSM9225665 BJNHem20 cells, WT, day 0, replicate 2 BJNHem20 cells, WT, day…
- GSM9225666 BJNHem20 cells, WT, day 0, replicate 3 BJNHem20 cells, WT, day…
- GSM9225667 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 0, replicate 1 BJNHem20 cells, OCIAD2 …
- GSM9225668 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 0, replicate 2 BJNHem20 cells, OCIAD2 …
- GSM9225669 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 0, replicate 3 BJNHem20 cells, OCIAD2 …
- GSM9225670 BJNHem20 cells, OCIAD2 OV, day 0, replicate 1 BJNHem20 cells, OCIAD2 …
- GSM9225671 BJNHem20 cells, OCIAD2 OV, day 0, replicate 2 BJNHem20 cells, OCIAD2 …
- GSM9225672 BJNHem20 cells, OCIAD2 OV, day 0, replicate 3 BJNHem20 cells, OCIAD2 …
- GSM9225673 BJNHem20 cells, WT, day 2, replicate 1 BJNHem20 cells, WT, day…
- GSM9225674 BJNHem20 cells, WT, day 2, replicate 2 BJNHem20 cells, WT, day…
- GSM9225675 BJNHem20 cells, WT, day 2, replicate 3 BJNHem20 cells, WT, day…
- GSM9225676 BJNHem20 cells, WT, day 2, replicate 4 BJNHem20 cells, WT, day…
- GSM9225677 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 2, replicate 1 BJNHem20 cells, OCIAD2 …
- GSM9225678 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 2, replicate 2 BJNHem20 cells, OCIAD2 …
- GSM9225679 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 2, replicate 3 BJNHem20 cells, OCIAD2 …
- GSM9225680 BJNHem20 cells, OCIAD2 CRISPR 33 (KO), day 2, replicate 4 BJNHem20 cells, OCIAD2 …
- GSM9225681 BJNHem20 cells, OCIAD2 OV, day 2, replicate 1 BJNHem20 cells, OCIAD2 …
- GSM9225682 BJNHem20 cells, OCIAD2 OV, day 2, replicate 2 BJNHem20 cells, OCIAD2 …
- GSM9225683 BJNHem20 cells, OCIAD2 OV, day 2, replicate 3 BJNHem20 cells, OCIAD2 …
- GSM9225684 BJNHem20 cells, OCIAD2 OV, day 2, replicate 4 BJNHem20 cells, OCIAD2 …
- GSE303051 Prolonged KRAS-MAPK Inhibition Induces Interferon-mediated Epithelial-to-Mesenchymal Transition and Reveals Therapeutic Opportunities. 30 samples shares mesenchymal, epithelial, transition
- GSE264118 Hypoxia Promotes an Adrenergic to Mesenchymal Transcriptional Program Transition in Neuroblastoma 24 samples shares mesenchymal, transition, promotes
- GSE256412 Epigenetic changes regulating the epithelial-mesenchymal transition in human trophoblast differentiation 22 samples shares mesenchymal, epithelial, transition
- GSE279017 Spatial transcriptomic analysis of head and neck squamous cell carcinoma reveals novel regulators of hybrid epithelial-to-mesenchymal transition 20 samples shares mesenchymal, epithelial, transition
- GSE298139 Therapy-resistance in AT/RT is driven by epithelial-mesenchymal transition, extracellular matrix changes, and enrichment of CD1A+ CD207+ dendritic cells [snRNA-seq] 16 samples shares mesenchymal, epithelial, transition
- GSE290615 miRNA/mRNA analysis of Chlamydia trachomatis-infected endometrial biopsies indicate increased TGF-β pathways drive epithelial-mesenchymal transition and regulatory T cell differentiation 15 samples shares mesenchymal, epithelial, transition
- GSE266169 Cellular crosstalk mediated by TGF-β drives epithelial-mesenchymal transition in patient-derived multilineage biliary organoids 14 samples shares mesenchymal, epithelial, transition
- GSE327697 Mast cells interact directly with colorectal cancer cells to promote epithelial-to-mesenchymal transition 12 samples shares mesenchymal, epithelial, transition
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.